DIAGNOSTIC SIGNIFICANCE OF ANTIBODIES SPECTRUM TO COXIELLA BURNETII IN I AND II PHASES


Cite item

Full Text

Abstract

The article discusses the results of a retrospective study for the presence of Coxiellosis serological markers in 723 blood sera from 537 febrile patients hospitalized in May-September 2015 in the regional infectious hospital in the Astrakhan region. Blood sera were screened by ELISA for the presence of IgG and IgM to II phase Coxiella burnetii (IgG II and IgM II, respectively). Samples, containing IgG II, wear detected IgG to I phase C. burnetii (IgG I). 92 seropositive C. burnetii patients (including 15 children’s) were identified. Characteristics of the antibody profiles in this study (IgG II, IgG II + IgM II, IgG II + IgG I, IgG II + IgM II + IgG I, IgM II) and their titers were given. The clinical picture is typical for acute infectious diseases was more often noted (diagnoses - acute respiratory disease / acute respiratory viral infection, adenovirus infection, Astrakhan spotted fever, coxiellosis) at spectrum detecting IgM II, IgM II + IgG II or IgG II (1: 800-1: 1600 titters). The «unknown etiology viral infection» diagnosis was more common among adults with any possible antibodies spectrum. Diagnostic criteria of acute Q fever and chronic coxsiellosis are discussed in the context of the serological testing results.

About the authors

Tatiana A. Chekanova

N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Health Ministry of Russia

Email: tchekanova74@mail.ru
PhD, senior researcher of laboratory for Rickettsia ecology, N.F. Gamaleya National Research Center for Epidemiology and Microbiology 123098, Moscow, Russia

S. N Shpynov

N.F. Gamaleya National Research Center for Epidemiology and Microbiology of the Health Ministry of Russia

Email: stan63@inbox.ru
доктор мед. наук, вед. науч. сотр., зав. лаб. экологии риккетсий ФГБУ НИЦЭМ им. Н.Ф. Гамалеи Минздрава России 123098, Moscow, Russia

S. Zh Netalieva

A.M. Nichogi Regional Infectious Clinical Hospital

Email: sveta-netalieva@mail.ru
врач клинико-диагностической лаборатории ГБУЗ AO «Областная инфекционная клиническая больница им. А.М. Ничоги» 414011, Astrakhan, Russia

M. A Babaeva

A.M. Nichogi Regional Infectious Clinical Hospital

зав. клинико-диагностической лаб. ГБУЗ АО «Областная инфекционная клиническая больница имени А.М. Ничоги» 414011, Astrakhan, Russia

References

  1. Maurin M., Raoult D. Q Fever. Clinical Microbiology Reviews. 1999. Oct; 12(4): 518-53.
  2. Kazar J. Coxiella burnetii infection. Annals of New York Academy Sciences. 2005. Dec; 1063: 105-14.
  3. Kampschreur LM, Delsing CE, Groenwold RH, Wegdam-Blans MC, Bleeker-Rovers CP, de Jager-Leclercq MG, et al. Chronic Q fever in the Netherlands 5 years after the start of the Q fever epidemic: results from the Dutch chronic Q fever database. Journal of Clinical Microbiology. 2014; 52(5): 1637- 43.
  4. Raoult D, Tissot-Dupont H, Foucault C, Gouvernet J, Fournier PE, Bernit E, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore). 2000; 79(2): 109-23.
  5. Лобан К.М., Лобзин Ю.В., Лукин Е.П. Риккетсиозы человека. Руководство для врачей. СПб.: ЭЛБИ-СП; 2002.
  6. Яковлев Э.А., Борисевич С.В., Попова А.Ю., Ежлова Е.Б., Демина Ю.В. Заболеваемость лихорадкой Ку в Российской Федерации и странах Европы: реалии и проблемы. Проблемы особо опасных инфекций. 2015; 4: 49-54.
  7. Карпенко С.Ф. Клинико-патогенетическое и прогностическое значение некоторых факторов резистентности у больных коксиеллезом. Диссертация на соискание ученой степени доктора медицинских наук, Астрахань, 2017.
  8. Raoult D. Chronic Q fever: Expert opinion versus literature analysis and consensus. Journal of Infection. 2012; 65 (2): 102- 8.
  9. Anderson A., Bijlmer H., Fournier P., Graves S., Hartzell J., Kersh G. J, et.al. Diagnosis and management of Q fever - United States, 2013: Recommendations from CDC and the Q Fever Working Group, MMWR, 2013; 62(3): 1-23.
  10. Чеканова Т.А., Пантюхина А.Н., Шпынов С.Н., Лучшев А.В., Нафеев А.А., Тарасевич И.В. Иммуноферментные тест-системы для дифференциального выявления антител к антигенам I и II фаз возбудителя Q-лихорадки Coxiella burnetii. В кн.: Молекулярная диагностика. M.; 2017; 2: 201-2.
  11. Чеканова Т.А., Шпынов С.Н., Пантюхина А.Н., Тарасевич И.В. Разработка и апробация иммуноферментных тест-систем для диагностики коксиеллеза и риккетсиозов. В кн.: Инфекционные болезни в современном мире: эволюция, текущие и будущие угрозы. Материалы X Ежегодного Всероссийского Конгресса по инфекционным болезням с международным участием. М.; 2018.
  12. Wegdam-Blans MC, Kampschreur LM, Deising CE, Bleeker-Rovers CP, Sprong T, van Kasteren ME, et al. Dutch Q fever Consensus Group. Chronic Q fever: review of the literature and a proposal of new diagnostic criteria. Journal of Infection. 2012; 64(3): 247-59.
  13. Eldin С., Mélenotte С., Mediannikov O., Ghigo E., Million M., Edouard S., et. al. From Q Fever to Coxiella burnetii Infection: a Paradigm Change. Clinical Microbiology Reviews. 2017; 30(1): 115-90.
  14. Jager MM, Weers-Pothoff G, Hermans MHA, Meekelenkamp JCE, Schellekens JJA, Renders NHM, et. al. Evaluation of a diagnostic algorithm for acute Q fever in an outbreak setting. Clinical and vaccine Immunology. 2011; (18): 963-8.
  15. Schneeberger PM, Hermans MH, van Hannen EJ, Schellekens JJ, Leenders AC, Wever PC. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clinical and vaccine Immunology. 2010;17(2): 286-90.
  16. Wielders CC, Teunis PF, Hermans MH, van der Hoek W, Schneeberger PM. Kinetics of antibody response to Coxiella burnetii infection (Q fever): Estimation of the seroresponse onset from antibody levels. Epidemics. 2015; 13: 37-43.
  17. Wielders CC, van Loenhout JA, Morroy G, Rietveld A, Notermans DW, Wever PC, Renders NH, Leenders AC, van der Hoek W, Schneeberger PM. Long-term serological follow-up of acute Q-fever patients after a large epidemic. PLoS One. 2015; 10(7): e0131848.
  18. Healy B., Woerden H., Raoult D., Graves S., Pitman J., Lloyd G., et.al. Chronic Q fever: different serological results in 3 countries-results of a follow-up study 6 years after a point source outbreak. Clinical Infectious Diseases. 2011; 52 (8): 1013-9.

Copyright (c) 2018 Eco-vector


 


This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies